| 51 |
12492611 | Quantification of heparin-induced TFPI release: a maximum release at low heparin dose. | 2002 Dec |
9 |
| 52 |
12714831 | Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance. | 2002 Oct |
8 |
| 53 |
11229821 | Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases. | 2001 Jan |
1 |
| 54 |
11254842 | Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor. | 2001 Feb |
3 |
| 55 |
11372675 | Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins. | 2001 May |
9 |
| 56 |
11380428 | Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. | 2001 May |
3 |
| 57 |
11434705 | The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients. | 2001 Jun |
10 |
| 58 |
11441984 | Tissue factor pathway inhibitor release induced by defibrotide and heparins. | 2001 Jul |
3 |
| 59 |
11457474 | Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates. | 2001 Jul 15 |
4 |
| 60 |
11668420 | Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma. | 2001 Oct |
14 |
| 61 |
11709459 | Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state. | 2001 Dec |
2 |
| 62 |
11772296 | Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders. | 2001 Nov |
3 |
| 63 |
11776326 | Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro. | 2001 Dec |
4 |
| 64 |
10664333 | Altered plasma antigen levels of tissue factor pathway inhibitor during open-heart surgery. | 2000 |
3 |
| 65 |
10847421 | Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins. | 2000 Jun |
6 |
| 66 |
10896252 | Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. | 2000 Jun |
7 |
| 67 |
10922378 | Tissue factor pathway inhibitor binds to platelet thrombospondin-1. | 2000 Oct 13 |
1 |
| 68 |
10928482 | Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. | 2000 Jul |
2 |
| 69 |
11132652 | In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy. | 2000 Dec |
2 |
| 70 |
11150580 | Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin. | 2000 Dec 1 |
5 |
| 71 |
11251341 | Physiological function of tissue factor pathway inhibitor and interaction with heparins. | 2000 |
8 |
| 72 |
9974412 | Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. | 1999 Feb |
2 |
| 73 |
10063992 | Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis. | 1999 Feb |
4 |
| 74 |
10065895 | Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris. | 1999 Jan 1 |
2 |
| 75 |
10235445 | Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. | 1999 Apr |
1 |
| 76 |
10336236 | Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor? | 1999 May 15 |
3 |
| 77 |
10397725 | Regulation of tissue factor pathway inhibitor expression in smooth muscle cells. | 1999 Jul 15 |
2 |
| 78 |
10479670 | Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. | 1999 Sep |
16 |
| 79 |
10494757 | High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria. | 1999 Sep |
2 |
| 80 |
10545520 | Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. | 1999 Nov |
1 |
| 81 |
10606880 | Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins. | 1999 Dec |
2 |
| 82 |
10613653 | Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes. | 1999 Dec |
2 |
| 83 |
11938732 | [Affection of aprotinin on tissue factor pathway inhibitor in peri-operation of cardiac direct vision operation]. | 1999 |
3 |
| 84 |
9622039 | Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. | 1998 Feb 1 |
1 |
| 85 |
9622042 | Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina. | 1998 Feb 1 |
5 |
| 86 |
9622211 | Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses. | 1998 Mar |
2 |
| 87 |
9651145 | A kinetic analysis of the interaction of human recombinant tissue factor pathway inhibitor with factor Xa utilizing and immunoassay and the effect of antithrombin III/heparin on the complex formation. | 1998 Feb 15 |
1 |
| 88 |
9669748 | Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction. | 1998 Mar 15 |
10 |
| 89 |
9674734 | Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action. | 1998 Jun |
11 |
| 90 |
9736420 | Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy. | 1998 Aug 15 |
8 |
| 91 |
9778325 | Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans. | 1998 Oct 20 |
1 |
| 92 |
9798992 | Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells. | 1998 Oct |
4 |
| 93 |
9819002 | A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans. | 1998 Sep |
3 |
| 94 |
10420071 | Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor. | 1998 Sep-Oct |
4 |
| 95 |
15992020 | Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders. | 1998 Jul |
3 |
| 96 |
9156410 | Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administration. | 1997 |
4 |
| 97 |
9187023 | The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man. | 1997 May 15 |
6 |
| 98 |
9200336 | Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients: effect of hyperinsulinemia. | 1997 |
2 |
| 99 |
9345040 | Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells. | 1997 Nov 1 |
1 |
| 100 |
9359432 | Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. | 1997 Oct 15 |
1 |